The CAR transgene has been identified within the 3′ untranslated region of PBX2, a gene related to the development of lymphomas, in a secondary T-cell lymphoma case previously treated with ciltacabtagene autoleucel, a commercial anti-BCMA product. The gene discussed is TNFRSF17; the disease is lymphoma.